Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

A clinical nomogram and recursive partitioning analysis to determine five-year disease-free survival in patients with thoracic esophageal carcinoma after radical surgery

Date

20 Dec 2015

Session

Poster presentation 2

Presenters

Shufei Yu

Citation

Annals of Oncology (2015) 26 (suppl_9): 125-147. 10.1093/annonc/mdv532

Authors

S. Yu, Z. Xiao, W. Deng, W. Ni, J. Yang, L. Tan, W. Zhang, Q. Wang, Z. Zhou, H. Zhang, J. Liang, T. Zhang

Author affiliations

  • Radiation Therapy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS), 100021 - Beijing/CN
More

Resources

Aim/Background

This investigation defined patient populations at high-, intermediate-, and low-risk of recurrence with thoracic esophageal carcinoma after radical surgery using clinical nomograms and recursive partitioning analysis (RPA).

Methods

A retrospective review of 3,480 patients diagnosed as esophageal carcinoma in Chinese Academy of Medical Science, Cancer hospital between January 2004 and May 2009 was performed. A database compiling 1,119 patents with thoracic esophageal carcinoma after surgery with or without postoperative radiation was created. Logistic analysis was performed to identify factors to be included in a RPA to predict for 5-year disease-free survival. A 5-year disease-free survival clinical nomogram was conducted and validated (c-index statistic).

Results

Median follow-up time was 86.1 months for all the patients. Length of tumor, treatment modality, upper margin,T stage, Lymph node metastatic ratio and vascular emboli were found to be statistically significant predictors of the 5-year disease-free survival. RPA classifications were defined as follows: low risk (5-year disease-free survival:55%): positive lymph node ratio >0.073; intermediate risk (5-year disease-free survival42%): T1-2 stage with lymph node metastatic ratio(LNMR) > 0.073 received surgery alone OR LNMR > 0.073 and received postoperative irradiation; high risk (5-year disease-free survival 10%):T3-4 stage, and LMNR > 0.073 and without postoperative irradiation. These classifications were highly statistically significant for overall survival (P < 0.001). A clinical nomogram containing the six factors for the prediction of 5-year disease-free survival was created(c-index 0.646).

Conclusions

A risk-adapted treatment approach can be applied for thoracic esophageal carcinoma after radical surgery using RPA categories and / or nomogram-based risk estimates. Postoperative irradiation might improve disease-free survival for T3-4 stage with LNMR >0.073.

Clinical trial identification

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings